RDY Earnings & Financial Statements
Dr. Reddy's Laboratories Limited
$12.27
-$0.22(-1.76%)
66
Overall
85
Value
72
Tech
42
Quality
Market Cap
$10.24B
Volume
3.12M
52W Range
$11.36 - $15.67
Target Price
$14.17
RDY earnings and financial statements: Dr. Reddy's Laboratories Limited's income statement, balance sheet and cash flow statement, annual and quarterly.
RDY Annual Financial Statements
| Fiscal year | 2025 | 2024 |
|---|---|---|
| Revenue | $325.54B | $279.16B |
| Cost of revenue | $135.11B | $115.56B |
| Operating income | $73.54B | $67.73B |
| EBITDA | $96.67B | $88.42B |
| Net income | $56.54B | $55.68B |
| EPS (diluted) | $67.78 | $66.80 |
| Fiscal year | 2025 | 2024 |
|---|---|---|
| Total assets | $492.99B | $387.52B |
| Total liabilities | $155.82B | $106.97B |
| Shareholders’ equity | $333.39B | $280.55B |
| Cash and equivalents | $14.65B | $7.11B |
| Long-term debt | $7.86B | $5.99B |
| Fiscal year | 2025 | 2024 |
|---|---|---|
| Operating cash flow | $46.43B | $45.43B |
| Free cash flow | $12.03B | $18.00B |
| Dividends paid | $6.66B | $6.65B |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | RDY | $12.27 | -1.8% | 3.12M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Dr. Reddy's Laboratories Limited Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW